New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls. Read the Q3 2026 report

Bristol Myers Squibb Company

BMY

Healthcare Drug Manufacturers General

Bristol Myers Squibb Company’s revenue for fiscal 2025 (year ended December 2025) was $48.2 billion, roughly unchanged from fiscal 2024.

Revenue
+6.93%
EPS
−2.78%
Free cash flow
−36.0%
Total debt
−12.5%

Quarter to September 2026, against a year earlier

59.43 1.09 +1.87%
Market cap
$119.3B
P/E
12.9×
Fwd P/E FY26e
12.0×
Dividend yield
4.32%
F-score
8/9
ROIC
13.2%
Net debt / EBITDA
2.6×
Payout ratio
0.6×

Bristol Myers Squibb Company (BMY) Revenue growth

Alert me on Revenue growth

Bristol Myers Squibb Company's revenue growth over the twelve months to Sep 30, 2026 was 4.16%, up 4.4 percentage points from fiscal 2025 (−0.22%). Over the past ten years it has ranged from −2.50% (fiscal 2023) to 62.6% (fiscal 2020); the current reading is higher than 27% of that period. That is below the Drug Manufacturers General industry median of 6.72% and below the Healthcare sector median of 8.85%.

Revenue growth, annual

Embed this chart

Annual newest first

Period Revenue growth Change (points)
FY2025 −0.22% (7.54)
FY2024 7.32% 9.82
FY2023 −2.50% (2.01)
FY2022 −0.49% (9.58)
FY2021 9.09% (53.53)
FY2020 62.6% 46.73
FY2019 15.9% 7.30
FY2018 8.59% 1.65
FY2017 6.94% (10.37)
FY2016 17.3% 13.02

Quarterly newest first

Period Revenue growth Change (points)
Sep 2026 6.93% 1.19
Jun 2026 5.74% 3.17
Mar 2026 2.57% 1.27
Dec 2025 1.30% (1.47)
43 more quarters

Against its own ten years

Low −2.50% High 62.6%
Ten-year median 7.32%
Current reading's percentile 27

Revenue growth against peers

Company Revenue growth
SNY Sanofi compare 26.3%
NVO Novo Nordisk A/S compare 11.1%
AMGN Amgen Inc. compare 8.15%
AZN AstraZeneca PLC compare 7.32%
GSK GSK PLC Sponsored ADR compare 6.90%
GILD Gilead Sciences, Inc. compare 6.54%
BMY Bristol Myers Squibb Company 4.16%
NVS Novartis AG compare 1.76%
PFE Pfizer Inc. compare 1.34%
Drug Manufacturers General industry median 6.72%
Healthcare sector median 8.85%
Market median 7.92%

What Revenue growth is

Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.

(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|

The full definition of Revenue growth →

More on BMY